FI875257A - Foerfarande foer framstaellning av nya difosfonsyraderivat. - Google Patents
Foerfarande foer framstaellning av nya difosfonsyraderivat. Download PDFInfo
- Publication number
- FI875257A FI875257A FI875257A FI875257A FI875257A FI 875257 A FI875257 A FI 875257A FI 875257 A FI875257 A FI 875257A FI 875257 A FI875257 A FI 875257A FI 875257 A FI875257 A FI 875257A
- Authority
- FI
- Finland
- Prior art keywords
- denotes
- het
- lower alkyl
- substituted
- hydrogen
- Prior art date
Links
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 208000022458 calcium metabolism disease Diseases 0.000 abstract 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/5532—Seven-(or more) membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/62—Isoquinoline or hydrogenated isoquinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19863640938 DE3640938A1 (de) | 1986-11-29 | 1986-11-29 | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindung enthaltende arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
FI875257A0 FI875257A0 (fi) | 1987-11-27 |
FI875257A true FI875257A (fi) | 1988-05-30 |
Family
ID=6315163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI875257A FI875257A (fi) | 1986-11-29 | 1987-11-27 | Foerfarande foer framstaellning av nya difosfonsyraderivat. |
Country Status (16)
Country | Link |
---|---|
US (1) | US4971958A (fi) |
EP (1) | EP0273190B1 (fi) |
JP (1) | JPS63154692A (fi) |
KR (1) | KR880006257A (fi) |
AT (1) | ATE62690T1 (fi) |
AU (1) | AU8169287A (fi) |
CS (1) | CS268842B2 (fi) |
DD (1) | DD269150A5 (fi) |
DE (2) | DE3640938A1 (fi) |
DK (1) | DK625787A (fi) |
FI (1) | FI875257A (fi) |
HU (1) | HU198948B (fi) |
IE (1) | IE873235L (fi) |
IL (1) | IL84570A0 (fi) |
PT (1) | PT86225B (fi) |
ZA (1) | ZA878746B (fi) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL84731A0 (en) * | 1986-12-19 | 1988-05-31 | Norwich Eaton Pharma | Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them |
GB8808138D0 (en) * | 1988-04-07 | 1988-05-11 | Leo Pharm Prod Ltd | Chemical compounds |
US4990503A (en) * | 1988-08-12 | 1991-02-05 | Yamanouchi Pharmaceutical Co., Ltd. | Heterocyclic bisphosphonic acid derivatives |
JPH0699457B2 (ja) * | 1988-08-12 | 1994-12-07 | 山之内製薬株式会社 | ヘテロ環ビスフォスフォン酸誘導体およびその医薬 |
MX21452A (es) * | 1989-07-07 | 1994-01-31 | Ciba Geigy Ag | Preparaciones farmaceuticas que se administran en forma topica. |
US5139786A (en) * | 1989-07-07 | 1992-08-18 | Ciba-Geigy Corporation | Topical formulations |
DE3930130A1 (de) * | 1989-09-09 | 1991-03-21 | Boehringer Mannheim Gmbh | Neue amidingruppen-haltige diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
DE69329199D1 (de) * | 1992-05-29 | 2000-09-14 | Procter & Gamble Pharma | Schwefel-enthaltende phosphonat-verbindungen zur behandlung von abnormalem calzium- und phosphat- metabolismus |
US5391743A (en) * | 1992-05-29 | 1995-02-21 | Procter & Gamble Pharmaceuticals, Inc. | Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque |
US5753634A (en) * | 1992-05-29 | 1998-05-19 | The Procter & Gamble Company | Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism |
AU666741B2 (en) * | 1992-05-29 | 1996-02-22 | Procter & Gamble Pharmaceuticals, Inc., The | Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism |
US5763611A (en) * | 1992-05-29 | 1998-06-09 | The Procter & Gamble Company | Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
DK0646119T3 (da) * | 1992-05-29 | 1998-12-14 | Procter & Gamble Pharma | Phosphonatforbindelser indeholdende kvaternært nitrogen til behandling af unormalt calcium- og phosphatstofskifte samt tan |
US6406714B1 (en) | 1992-12-02 | 2002-06-18 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids |
US6677320B2 (en) | 2000-01-20 | 2004-01-13 | Hoffmann-La Roches Inc. | Parenteral bisphosphonate composition with improved local tolerance |
CA2407747C (en) | 2000-05-05 | 2008-03-11 | F. Hoffmann-La Roche Ag | Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
AU2002360619B2 (en) * | 2001-12-21 | 2006-10-05 | Allergan Pharmaceuticals International Limited | Method for the treatment of bone disorders |
CN100551377C (zh) | 2002-05-10 | 2009-10-21 | 弗·哈夫曼-拉罗切有限公司 | 用于治疗和预防骨质疏松症的二膦酸 |
US20040138180A1 (en) * | 2002-10-03 | 2004-07-15 | Barr Laboratories, Inc. | Bisphosphonate composition and process for the preparation thereof |
PL212072B1 (pl) * | 2002-12-20 | 2012-08-31 | Hoffmann La Roche | Tabletka zawierająca jako substancję czynną do 250 mg kwasu ibandronowego oraz sposób jej wytwarzania |
EP2350076B1 (en) * | 2008-09-22 | 2013-08-21 | Isis Innovation Ltd | Imidazo[1,2- alpha]pyridinyl bisphosphonates |
CN102630227B (zh) * | 2009-10-26 | 2016-03-23 | 沃纳奇尔科特有限责任公司 | 用于治疗骨代谢紊乱的双膦酸盐化合物 |
US8748097B1 (en) | 2011-12-02 | 2014-06-10 | President And Fellows Of Harvard College | Identification of agents for treating calcium disorders and uses thereof |
PL407922A1 (pl) | 2014-04-16 | 2015-10-26 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością | Nowe bisfosfoniany i ich zastosowanie |
CN111225672B (zh) | 2017-10-16 | 2023-09-29 | 清华大学 | 甲羟戊酸通路抑制剂及其药物组合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1958123C3 (de) * | 1969-11-19 | 1978-09-28 | Henkel Kgaa, 4000 Duesseldorf | Verfahren zur Herstellung von 1 -Aminoalkan-1,1 -diphosphonsäuren oder deren Salzen |
US3988443A (en) * | 1973-08-27 | 1976-10-26 | Henkel & Cie G.M.B.H. | Azacycloalkane-2,2-diphosphonic acids |
JPS5359674A (en) * | 1976-10-25 | 1978-05-29 | Nissan Chem Ind Ltd | 1-piperidinoalkane-1,1-diphosphonic acid derivatives and herbicidescontaining the same as active agent |
DE2745083C2 (de) * | 1977-10-07 | 1985-05-02 | Henkel KGaA, 4000 Düsseldorf | Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung |
DE3428524A1 (de) * | 1984-08-02 | 1986-02-13 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
IL77243A (en) * | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
US4761406A (en) * | 1985-06-06 | 1988-08-02 | The Procter & Gamble Company | Regimen for treating osteoporosis |
DE3626058A1 (de) * | 1986-08-01 | 1988-02-11 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
US4739036A (en) * | 1986-08-15 | 1988-04-19 | Goodyear Tire & Rubber Company | Rubber vulcanization agents and methods for their preparation |
IL84497A (en) * | 1986-11-21 | 1994-10-21 | Ciba Geigy Ag | History 2-) Imidazol-1-yl (ethane-1,1-diphosphonic acid, their preparation and pharmaceutical preparations containing them |
ES2039259T3 (es) * | 1986-11-21 | 1993-09-16 | Ciba-Geigy Ag | Procedimiento para la obtencion de acidos azacicloalquil alcandifosfonicos aromaticamente substituidos. |
IL84731A0 (en) * | 1986-12-19 | 1988-05-31 | Norwich Eaton Pharma | Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them |
-
1986
- 1986-11-29 DE DE19863640938 patent/DE3640938A1/de not_active Withdrawn
-
1987
- 1987-11-21 AT AT87117191T patent/ATE62690T1/de not_active IP Right Cessation
- 1987-11-21 EP EP87117191A patent/EP0273190B1/de not_active Expired - Lifetime
- 1987-11-21 DE DE8787117191T patent/DE3769452D1/de not_active Expired - Lifetime
- 1987-11-23 IL IL84570A patent/IL84570A0/xx unknown
- 1987-11-23 ZA ZA878746A patent/ZA878746B/xx unknown
- 1987-11-25 CS CS878510A patent/CS268842B2/cs unknown
- 1987-11-25 AU AU81692/87A patent/AU8169287A/en not_active Abandoned
- 1987-11-26 JP JP62296290A patent/JPS63154692A/ja active Pending
- 1987-11-26 PT PT86225A patent/PT86225B/pt not_active IP Right Cessation
- 1987-11-27 DK DK625787A patent/DK625787A/da not_active Application Discontinuation
- 1987-11-27 IE IE873235A patent/IE873235L/xx unknown
- 1987-11-27 DD DD87309581A patent/DD269150A5/de not_active IP Right Cessation
- 1987-11-27 HU HU875355A patent/HU198948B/hu not_active IP Right Cessation
- 1987-11-27 FI FI875257A patent/FI875257A/fi not_active Application Discontinuation
- 1987-11-28 KR KR870013477A patent/KR880006257A/ko not_active Application Discontinuation
-
1989
- 1989-05-23 US US07/356,567 patent/US4971958A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR880006257A (ko) | 1988-07-22 |
DE3769452D1 (de) | 1991-05-23 |
FI875257A0 (fi) | 1987-11-27 |
DK625787A (da) | 1988-05-30 |
DE3640938A1 (de) | 1988-06-01 |
HUT46024A (en) | 1988-09-28 |
PT86225A (de) | 1987-12-01 |
AU8169287A (en) | 1988-06-02 |
DD269150A5 (de) | 1989-06-21 |
ZA878746B (en) | 1988-05-18 |
IL84570A0 (en) | 1988-04-29 |
CS851087A2 (en) | 1989-08-14 |
ATE62690T1 (de) | 1991-05-15 |
DK625787D0 (da) | 1987-11-27 |
IE873235L (en) | 1988-05-29 |
PT86225B (pt) | 1990-11-07 |
HU198948B (en) | 1989-12-28 |
EP0273190A1 (de) | 1988-07-06 |
JPS63154692A (ja) | 1988-06-27 |
EP0273190B1 (de) | 1991-04-17 |
US4971958A (en) | 1990-11-20 |
CS268842B2 (en) | 1990-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI875257A0 (fi) | Foerfarande foer framstaellning av nya difosfonsyraderivat. | |
ES2148156T3 (es) | Imidazopiridinas. | |
DE3268225D1 (de) | 9-(2-(3-indolyl)ethyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones | |
FI906296A0 (fi) | Nya metylenbisfosfonsyrederivat. | |
ES557783A0 (es) | Un procedimiento para la preparacion de derivados de b-lactama | |
KR920007999A (ko) | 4-또는 5-치환된 피리딘-2-카복실산. 이들의 제조방법 및 약제로서 이들의 용도 | |
MC1919A1 (fr) | Derives de l'imidazole | |
ATE109480T1 (de) | N-(5,6,7,8-tetrahydropyrido(2,3-d)pyrimidin-6-y - alkanoyl)-glutaminsäure-derivate. | |
TW225989B (fi) | ||
NO891608D0 (no) | Heterotetracykliske laktamderivater. | |
ES8501762A1 (es) | Procedimiento para preparar nuevos derivados de piperidina | |
ES2042727T3 (es) | Acidos 1,3,4,9-tetrahidropirano(3,4-b)indol-1-acetico. | |
ES2032838T3 (es) | Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |
Owner name: BOEHRINGER MANNHEIM GMBH |